Loading…
sealvo.com · USPTO Trademark Record
https://sealvo.com/oncoreveal-90532971
Section 8 declaration window
December 31, 2030
1517 days remaining

Advertising; business management, organization and administration; office functions.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.
ONCOREVEAL (Serial No. 90532971), Registration No. 7634070, is a registered US trademark filed on Feb 17, 2021 by Pillar Biosciences, Inc.. This trademark covers Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).
First use anywhere: Mar 16, 2022
First use in commerce: Mar 16, 2022
Advertising; business management, organization and administration; office functions.
First use anywhere: Mar 16, 2022
First use in commerce: Mar 16, 2022
Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.
First use anywhere: Mar 16, 2022
First use in commerce: Mar 16, 2022
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.
This description is as filed with the USPTO and defines the scope of trademark protection.
AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.
Free USPTO lookups by name, owner, or serial number. No account needed.
Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.